Cetuximab Combination Fails to Deliver Benefit in HNSCC
Links shared publicly online about this topic.
- 35total visits
Cetuximab Combination Fails to Deliver Benefit in HNSCC
Patients with locally advanced head and neck cancer gained no survival benefit with the addition of cetuximab to chemoradiation.
View full resource at onclive.com
Tags: Cancer, Head and Neck Cancer, Skin Cancer, Squamous Cell Carcinoma, Erbitux
Most Recently Shared on August 30, 2011 at 2:09 pm By:
Cetuximab Combination Fails to Deliver Benefit in advanced or metastatic head and neck squamous cell carcinoma http://t.co/zC0uhP9
Advertisement
